Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Johnson & Johnson Stock Quote

Johnson & Johnson (NYSE: JNJ)

$161.84
(0.9%)
$1.39
Price as of February 23, 2024, 4:00 p.m. ET

You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Johnson & Johnson Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
JNJ +2.61% +18.48% +3.45% +2,062%
S&P +27.46% +82.16% +12.74% +1,315%

Johnson & Johnson Company Info

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and MedTech. The Consumer Health segment includes products focused on personal healthcare used in the Skin Health/Beauty, Over-the-Counter medicines, Baby Care, Oral Care, Women’s Health and Wound Care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The MedTech segment offers products used in the interventional solutions. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

News & Analysis

The Fool has written over 3,200 articles on Johnson & Johnson.

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.